<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">diaendo</journal-id><journal-title-group><journal-title xml:lang="ru">Сахарный диабет</journal-title><trans-title-group xml:lang="en"><trans-title>Diabetes mellitus</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0351</issn><issn pub-type="epub">2072-0378</issn><publisher><publisher-name>Endocrinology research centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/DM12765</article-id><article-id custom-type="elpub" pub-id-type="custom">diaendo-12765</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original Studies</subject></subj-group></article-categories><title-group><article-title>Уровень маркеров окислительного повреждения липидов и ДНК у мужчин с сахарным диабетом 1 типа и разным уровнем альбуминурии</article-title><trans-title-group xml:lang="en"><trans-title>Markers of oxidative damage lipids and DNA in men with type 1 diabetes mellitus and different levels of albuminuria</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3255-2013</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Даренская</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Darenskaya</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Даренская Марина Александровна, доктор медицинских наук</p><p>664003, Иркутск, ул. Тимирязева, д. 16</p><p>Researcher ID: <ext-link xlink:href="https://publons.com/researcher/O-4490-2015/" ext-link-type="uri">O-4490-2015</ext-link>;</p><p>Scopus Author ID: <ext-link xlink:href="http://www.scopus.com/inward/authorDetails.url?authorID=55453341400&amp;partnerID=MN8TOARS" ext-link-type="uri"> 55453341400</ext-link>;</p><p>eLibrary SPIN: 3327-4213</p></bio><bio xml:lang="en"><p>Marina A. Darenskaya, PhD in Biology</p><p>16 Timiryazeva street, 664003, Irkutsk</p><p>Researcher ID: <ext-link xlink:href="https://publons.com/researcher/O-4490-2015/" ext-link-type="uri">O-4490-2015</ext-link>;</p><p>Scopus Author ID: <ext-link xlink:href="http://www.scopus.com/inward/authorDetails.url?authorID=55453341400&amp;partnerID=MN8TOARS" ext-link-type="uri"> 55453341400</ext-link>;</p><p>eLibrary SPIN: 3327-4213</p></bio><email xlink:type="simple">marina_darenskaya@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2546-6320</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чугунова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Chugunova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чугунова Елена Владимировна </p><p>Иркутск</p><p>eLibrary SPIN: 9598-2823</p></bio><bio xml:lang="en"><p>Elena V. Chugunova, MD</p><p>Irkutsk</p><p>eLibrary SPIN: 9598-2823</p></bio><email xlink:type="simple">e.v_chugunova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2124-6328</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колесников</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolesnikov</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Колесников Сергей Иванович, доктор медицинских наук, профессор, академик РАН</p><p>Иркутск</p><p>eLibrary SPIN: 1752-6695</p></bio><bio xml:lang="en"><p>Sergey I. Kolesnikov, MD, PhD, Professor, Member of the RAS</p><p>Irkutsk</p><p>eLibrary SPIN: 1752-6695</p></bio><email xlink:type="simple">sikolesnikov1@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1263-5527</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гребенкина</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Grebenkina</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гребенкина Людмила Анатольевна, доктор биологических наук</p><p>Иркутск</p><p>eLibrary SPIN: 6194-5785</p></bio><bio xml:lang="en"><p>Lyudmila A. Grebenkina, PhD in Biology</p><p>Irkutsk</p><p>eLibrary SPIN: 6194-5785</p></bio><email xlink:type="simple">greblud@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6512-1335</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Семенова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Semenova</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Семенова Наталья Викторовна, доктор биологических наук</p><p>Иркутск</p><p>eLibrary SPIN: 6606-0160</p></bio><bio xml:lang="en"><p>Natalja V. Semenova, PhD</p><p>Irkutsk</p><p>eLibrary SPIN: 6606-0160</p></bio><email xlink:type="simple">natkor_84@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1926-9694</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никитина</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikitina</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Никитина Ольга Андреевна, кандидат биологических наук</p><p>Иркутск</p><p>eLibrary SPIN: 1799-4973</p></bio><bio xml:lang="en"><p>Olga A. Nikitina, PhD in Biology</p><p>Irkutsk</p><p>eLibrary SPIN: 1799-4973</p></bio><email xlink:type="simple">olga_tolpygina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3354-2992</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колесникова</surname><given-names>Л. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolesnikova</surname><given-names>L. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Колесникова Любовь Ильинична, доктор медицинских наук, профессор, академик РАН</p><p>Иркутск</p><p>eLibrary SPIN: 1584-0281</p></bio><bio xml:lang="en"><p>Lyubov I. Kolesnikova, MD, PhD, Professor, Member of the RAS</p><p>Irkutsk</p><p>eLibrary SPIN: 1584-0281</p></bio><email xlink:type="simple">kolesnikova20121@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научный центр проблем здоровья семьи и репродукции человека</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Scientific Centre for Family Health and Human Reproduction Problems</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>25</day><month>03</month><year>2022</year></pub-date><volume>25</volume><issue>2</issue><fpage>120</fpage><lpage>127</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Даренская М.А., Чугунова Е.В., Колесников С.И., Гребенкина Л.А., Семенова Н.В., Никитина О.А., Колесникова Л.И., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Даренская М.А., Чугунова Е.В., Колесников С.И., Гребенкина Л.А., Семенова Н.В., Никитина О.А., Колесникова Л.И.</copyright-holder><copyright-holder xml:lang="en">Darenskaya M.A., Chugunova E.V., Kolesnikov S.I., Grebenkina L.A., Semenova N.V., Nikitina O.A., Kolesnikova L.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.dia-endojournals.ru/jour/article/view/12765">https://www.dia-endojournals.ru/jour/article/view/12765</self-uri><abstract><sec><title>ОБОСНОВАНИЕ</title><p>ОБОСНОВАНИЕ. Диабетическая нефропатия (ДН) — специфическое поражение почек, которым страдают до 40% пациентов с сахарным диабетом 1 типа (СД1). До сих пор имеется недостаточно знаний об активности реакций окислительного стресса у больных СД1 с разным уровнем альбуминурии.</p></sec><sec><title>ЦЕЛЬ</title><p>ЦЕЛЬ. Оценить у мужчин с СД1 и разными уровнями альбуминурии уровни показателей окислительного повреждения липидов, ДНК и антиоксидантной защиты.</p></sec><sec><title>МАТЕРИАЛЫ И МЕТОДЫ</title><p>МАТЕРИАЛЫ И МЕТОДЫ. Исследование проводилось в течение 2018–2019 гг. В основную группу были включены 56 мужчин репродуктивного возраста с СД1, разделенных на 2 группы: 24 пациента с альбуминурией уровня А1 (группа А1) и 32 пациента с альбуминурией уровня А2 (группа А2). Контрольную группу составили 28 здоровых мужчин. Произведена оценка содержания показателей окислительного стресса, а также активности различных звеньев системы антиоксидантной защиты. Использованы спектрофотометрические, флуориметрические и иммуноферментные методы исследования.</p></sec><sec><title>РЕЗУЛЬТАТЫ</title><p>РЕЗУЛЬТАТЫ. У пациентов группы А1 в сравнении с контролем отмечались более высокие значения медианы первичных — диеновых конъюгатов, вторичных — кетодиенов и сопряженных триенов, конечных — шиффовых оснований продуктов липопероксидации и 8-гидрокси-2’-деоксигуанозина в сравнении с контролем. Подобные изменения были выявлены также у пациентов группы А2. Межгрупповые различия касались повышенных значений медианы вторичных продуктов перекисного окисления, реагирующих с тиобарбитуровой кислотой, и 8-гидрокси-2’-деоксигуанозина у пациентов группы А2 в сравнении с группой А1. Активность системы антиоксидантной защиты в группе А1 относительно контроля характеризовалась повышенными значениями медиан глутатионпероксидазы, восстановленного и окисленного глутатионов и ретинола. У пациентов группы А2 в сравнении с контролем отмечались более высокие значения медиан глутатионпероксидазы, восстановленного и окисленного глутатионов. Корреляционный анализ в группе А1 показал наличие тесных взаимосвязей длительности заболевания с продуктами липопероксидации, уровня гликированного гемоглобина с 8-гидрокси-2’-деоксигуанозином. В группе А2 отмечались зависимости показателей соотношения альбумин/креатинин с длительностью заболевания и скорости клубочковой фильтрации с уровнем креатинина.</p></sec><sec><title>ЗАКЛЮЧЕНИЕ</title><p>ЗАКЛЮЧЕНИЕ. У мужчин с СД1 вне зависимости от уровня альбуминурии отмечаются более высокие значения параметров окислительного повреждения липидов и ДНК, а также наличие тесных взаимосвязей этих показателей с длительностью заболевания, что может быть использовано для разработки потенциальных стратегий профилактики и ранней терапии ДН</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>BACKGROUND</title><p>BACKGROUND: Diabetic nephropathy is a specific kidney damage that affects up to 40% of type 1 diabetes mellitus patients. There is still insufficient knowledge about oxidative stress at the different levels of albuminuria.</p></sec><sec><title>AIM</title><p>AIM: To assess the indicators of oxidative damage to lipids, DNA and antioxidant defense in men with type 1 diabetes mellitus and albuminuria different levels.</p></sec><sec><title>MATERIALS AND METHODS</title><p>MATERIALS AND METHODS: The study was conducted during 2018–2019. The main group included 56 men of reproductive age with type 1 diabetes mellitus (T1DM) divided into 2 groups: 24 patients with albuminuria level A1 (group A1) and 32 patients with albuminuria level A2 (group A2). The control group consisted of 28 healthy men. The oxidative stress indicators content, as well as the activity of antioxidant defense system various links was evaluated. Spectrophotometric, fluorimetric and enzyme immunoassay methods were used.</p></sec><sec><title>RESULTS</title><p>RESULTS: In patients of the A1 group there were higher values of the median of primary — conjugated dienes, secondary — ketodienes and conjugated trienes, final — Schiff bases products and 8-hydroxy-2’-deoxyguanosine in comparison with the control. Similar changes in patients of the A2 group were found. Intergroup differences related to increased median values of TBARs and 8-hydroxy-2’-deoxyguanosine in patients of the A2 group compared with A1 group. The activity of the antioxidant defense system in A1 group relative to the control by increased values of the glutathione peroxidase, reduced glutathione, oxidized glutathione median, and retinol was characterized. A2 group had higher values of glutathione peroxidase, reduced glutathione and oxidized glutathione medians in comparison with controls. Correlation analysis in A1 group showed the relationships between the duration of the disease and the products of lipid peroxidation, glycated hemoglobin with 8-hydroxy-2’-deoxyguanosine. In A2 group, there was a relationship between the albumin/creatinine ratio and the duration of the disease, glomerular filtration rate and creatinine level.</p></sec><sec><title>CONCLUSION</title><p>CONCLUSION: In men with T1DM, regardless of the albuminuria level, there are higher values of the oxidative damage lipids and DNA parameters, as well as the presence of close relationships between these parameters and the duration of the disease, which can be used to develop potential strategies for the prevention and early therapy of diabetic nephropathy.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>сахарный диабет 1 типа</kwd><kwd>мужчины</kwd><kwd>нефропатия</kwd><kwd>окислительный стресс</kwd><kwd>8-гидрокси-2’-деоксигуанозин</kwd></kwd-group><kwd-group xml:lang="en"><kwd>type 1 diabetes mellitus</kwd><kwd>men</kwd><kwd>nephropathy</kwd><kwd>oxidative stress</kwd><kwd>8-hydroxy-2’-deoxyguanosine</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено в рамках государственной бюджетной темы ФГБНУ «Научный центр проблем здоровья семьи и репродукции человека» «Патофизиологические механизмы и генетико-метаболические предикторы сохранения репродуктивного здоровья и долголетия в различных возрастных, гендерных и этнических группах» № 121022500180-6</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">International Diabetes Atlas, 2019.</mixed-citation><mixed-citation xml:lang="en">International Diabetes Atlas, 2019.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И., Шестакова М.В., Викулова О.К., и др. Сахарный диабет в Российской Федерации: распространенность, заболеваемость, смертность, параметры углеводного обмена и структура сахароснижающей терапии по данным Федерального регистра сахарного диабета, статус 2017 г. // Сахарный диабет. — 2018. — Т. 21. — №3. — C. 144-159. doi: https://doi.org/10.14341/DM9686</mixed-citation><mixed-citation xml:lang="en">Dedov II, Shestakova MV, Vikulova OK, et al. Diabetes mellitus in the Russian Federation: prevalence, morbidity, mortality, parameters of carbohydrate metabolism and the structure of hypoglycemic therapy according to the Federal Register of Diabetes Mellitus, status 2017. Diabetes mellitus. 2018;21(3):144-159. (In Russ.). doi: https://doi.org/10.14341/DM9686</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И., Шестакова М.В., Майоров А.Ю., и др. Сахарный диабет 1 типа у взрослых // Сахарный диабет. — 2020. — Т. 23. — №S1. doi: https://doi.org/10.14341/DM23S1</mixed-citation><mixed-citation xml:lang="en">Dedov II, Shestakova MV, Mayorov AYu, et al. Type 1 diabetes mellitus in adults // Diabetes mellitus. 2020;23(S1). (In Russ.). doi: https://doi.org/10.14341/DM23S1</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Paul S, Ali A, Katare R. Molecular complexities underlying the vascular complications of diabetes mellitus – A comprehensive review. J Diabetes Complications. 2020;34(8):107613. doi: https://doi.org/10.1016/j.jdiacomp.2020.107613</mixed-citation><mixed-citation xml:lang="en">Paul S, Ali A, Katare R. Molecular complexities underlying the vascular complications of diabetes mellitus – A comprehensive review. J Diabetes Complications. 2020;34(8):107613. doi: https://doi.org/10.1016/j.jdiacomp.2020.107613</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Selby NM, Taal MW. An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines. Diabetes, Obesity and Metabolism. 2020;22:3-15. doi: https://doi.org/10.1111/dom.14007</mixed-citation><mixed-citation xml:lang="en">Selby NM, Taal MW. An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines. Diabetes, Obesity and Metabolism. 2020;22:3-15. doi: https://doi.org/10.1111/dom.14007</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Sagoo MK, Gnudi L. Diabetic nephropathy: an overview. Diabetic Nephropathy. 2020:3-7. doi: https://doi.org/10.1007/978-1-4939-9841-8_1</mixed-citation><mixed-citation xml:lang="en">Sagoo MK, Gnudi L. Diabetic nephropathy: an overview. Diabetic Nephropathy. 2020:3-7. doi: https://doi.org/10.1007/978-1-4939-9841-8_1</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Щукина А.А., Бобкова И.Н., Шестакова М.В., и др. Экскреция с мочой маркеров повреждения подоцитов у больных сахарным диабетом // Терапевтический архив. — 2015. — Т. 87. — №10. — С. 62-66. doi: https://doi.org/10.17116/terarkh2015871062-66</mixed-citation><mixed-citation xml:lang="en">Shchukina AA, Bobkova IN, Shestakova MV, et al. Urinary excretion of markers of podocyte damage in patients with diabetes. Therapeutic archive. 2015;87(10):62-66. (In Russ.). doi: https://doi.org/10.17116/terarkh2015871062-66</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Шестакова М.В., Шамхалова М.Ш., Ярек-Мартынова И.Я., и др. Сахарный диабет и хроническая болезнь почек: достижения, нерешенные проблемы и перспективы лечения // Сахарный диабет. — 2011. — Т. 14. — №1. — C. 81-88. doi: https://doi.org/10.14341/2072-0351-6254</mixed-citation><mixed-citation xml:lang="en">Shestakova MV, Shamkhalova MSh, Yarek-Martynova IYa, et al. Diabetes mellitus and chronic kidney disease: achievements, unresolved problems and treatment prospects. Diabetes mellitus. 2011;14(1):81-88. (In Russ.). doi: https://doi.org/10.14341/2072-0351-6254</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Шестакова М.В. Сахарный диабет и хроническая болезнь почек: возможности прогнозирования, ранней диагностики и нефропротекции в XXI веке // Терапевтический архив. — 2016. — Т. 88. — № 6. — C. 84-88. doi: https://doi.org/10.17116/terarkh201688684-88</mixed-citation><mixed-citation xml:lang="en">Shestakova MV. Diabetes mellitus and chronic kidney disease: possibilities of prediction, early diagnosis and nephroprotection in the XXI century. Therapeutic archive. 2016;88(6):84-88. (In Russ.). doi: https://doi.org/10.17116/terarkh201688684-88</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Yang S, Han Y, Liu J, et al. Mitochondria: a novel therapeutic target in diabetic nephropathy. Current medicinal chemistry. 2017;24(29):3185-3202. doi: https://doi.org/10.2174/0929867324666170509121003</mixed-citation><mixed-citation xml:lang="en">Yang S, Han Y, Liu J, et al. Mitochondria: a novel therapeutic target in diabetic nephropathy. Current medicinal chemistry. 2017;24(29):3185-3202. doi: https://doi.org/10.2174/0929867324666170509121003</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Saxena S, Mathur A, Kakkar P. Critical role of mitochondrial dysfunction and impaired mitophagy in diabetic nephropathy. Journal of cellular physiology. 2019;234(11):19223-19236. doi: https://doi.org/10.1002/jcp.28712</mixed-citation><mixed-citation xml:lang="en">Saxena S, Mathur A, Kakkar P. Critical role of mitochondrial dysfunction and impaired mitophagy in diabetic nephropathy. Journal of cellular physiology. 2019;234(11):19223-19236. doi: https://doi.org/10.1002/jcp.28712</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Колесникова Л.И., Даренская М.А., Колесников С.И. Свободнорадикальное окисление: взгляд патофизиолога // Бюллетень сибирской медицины. — 2017. — Т. 16. — №4. — С. 16-29. doi: https://doi.org/10.20538/1682-0363-2017-4-16–29</mixed-citation><mixed-citation xml:lang="en">Kolesnikova LI, Darenskaya MA, Kolesnikov SI. Free radical oxidation: a pathophysiologist’s view. Bulletin of Siberian Medicine. 2017;16(4):16-29. (In Russ.). doi: https://doi.org/10.20538/1682-0363-2017-4-16–29</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Yaribeygi H, Sathyapalan T, Atkin SL, Sahebkar A. Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus. Oxid Med Cell Longev. 2020;2020:1-13. doi: https://doi.org/10.1155/2020/8609213</mixed-citation><mixed-citation xml:lang="en">Yaribeygi H, Sathyapalan T, Atkin SL, Sahebkar A. Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus. Oxid Med Cell Longev. 2020;2020:1-13. doi: https://doi.org/10.1155/2020/8609213</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lassén E, Daehn IS. Molecular Mechanisms in Early Diabetic Kidney Disease: Glomerular Endothelial Cell Dysfunction. Int J Mol Sci. 2020;21(24):9456. doi: https://doi.org/10.3390/ijms21249456</mixed-citation><mixed-citation xml:lang="en">Lassén E, Daehn IS. Molecular Mechanisms in Early Diabetic Kidney Disease: Glomerular Endothelial Cell Dysfunction. Int J Mol Sci. 2020;21(24):9456. doi: https://doi.org/10.3390/ijms21249456</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Vodošek Hojs N, Bevc S, Ekart R, et al. Oxidative stress markers in chronic kidney disease with emphasis on diabetic nephropathy. Antioxidants. 2020;9(10):925. doi: https://doi.org/10.3390/antiox9100925</mixed-citation><mixed-citation xml:lang="en">Vodošek Hojs N, Bevc S, Ekart R, et al. Oxidative stress markers in chronic kidney disease with emphasis on diabetic nephropathy. Antioxidants. 2020;9(10):925. doi: https://doi.org/10.3390/antiox9100925</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Turpin C, Catan A, Guerin-Dubourg A, et al. Enhanced oxidative stress and damage in glycated erythrocytes. PloS One. 2020;15(7):e0235335. doi: https://doi.org/10.1371/journal.pone.0235335</mixed-citation><mixed-citation xml:lang="en">Turpin C, Catan A, Guerin-Dubourg A, et al. Enhanced oxidative stress and damage in glycated erythrocytes. PloS One. 2020;15(7):e0235335. doi: https://doi.org/10.1371/journal.pone.0235335</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Ларина И.И., Северина А.С., Шамхалова М.Ш., и др. Осложнения хронической болезни почек у пациентов с сахарным диабетом 1 типа после сочетанной трансплантации почки и поджелудочной железы-потенциальная роль окислительного стресса и конечных продуктов гликирования // Сахарный диабет. — 2019. — Т. 22. — №5. — С. 405-416. doi: https://doi.org/10.14341/DM10312</mixed-citation><mixed-citation xml:lang="en">Larina II, Severina AS, Shamkhalova M Sh, et al. Complications of chronic kidney disease in patients with type 1 diabetes mellitus after combined kidney and pancreas transplantation — the potential role of oxidative stress and end glycation products. Diabetes mellitus. 2019;22(5):405-416. (In Russ.). doi: https://doi.org/10.14341/DM10312</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Черников А.А., Северина А.С., Шамхалова М.Ш., Шестакова М.В. Роль механизмов «метаболической памяти» в развитии и прогрессировании сосудистых осложнений сахарного диабета // Сахарный диабет. — 2017. — Т. 20. — №2. — С. 126-134. doi: https://doi.org/10.14341/7674</mixed-citation><mixed-citation xml:lang="en">Chernikov AA, Severina AS, Shamkhalova MSh, Shestakova MV. The role of metabolic memory mechanisms in the development and progression of vascular complications of diabetes mellitus. Diabetes mellitus. 2017;20(2):126-134. (In Russ.). doi: https://doi.org/10.14341/7674</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Григорян О.Р., Андреева Е.Н., Дедов И.И. Персонализированный подход к проблеме репродуктивного здоровья при эндокринопатиях // Терапевтический архив. — 2018. — Т. 90. — № 4. — C. 81-84. doi: https://doi.org/10.26442/terarkh201890481-84</mixed-citation><mixed-citation xml:lang="en">Grigoryan OR, Andreeva EN, Dedov II. Personalized strategies in reproductive medicine for patients with endocrine disorders. // Therapeutic archive. 2018;90(4):81-84. (In Russ.). doi: https://doi.org/10.26442/terarkh201890481-84</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И., Шестакова М.В., Майоров А.Ю., и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом: Клинические рекомендации (Вып. 9) // Сахарный диабет. — 2019. — Т. 22. — №S1. — С. 1-144. doi: https://doi.org/10.14341/DM221S1</mixed-citation><mixed-citation xml:lang="en">Dedov II, Shestakova MV, Mayorov AYu, et al. Standards of specialized diabetes care. Diabetes Mellitus. 2019;22(S1):1-144 (In Russ.). doi: https://doi.org/10.14341/DM221S1</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Волчегорский И.А., Налимов А.Г., Яровинский Б.Г., и др. Сопоставление различных подходов к определению продуктов перекисного окисления липидов в гептан-изопропанольных экстрактах крови // Вопросы медицинской химии. — 1989. — Т. 35. — №1. — С. 127-131.</mixed-citation><mixed-citation xml:lang="en">Volchegorskiy IA, Nalimov AG, Yarovinskiy BG, et al. Comparison of different approaches to the determination of lipid peroxidation products in heptane-isopropanol extracts of blood. Questions of medicinal chemistry. 1989;35(1):127-131. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Гаврилов В.Б., Гаврилова А.Р., Мажуль Л.М. Анализ методов определения продуктов перекисного окисления липидов в сыворотке крови по тесту с тиобарбитуровой кислотой // Вопросы медицинской химии. — 1987. — Т. 33. — №1. — С. 118–122.</mixed-citation><mixed-citation xml:lang="en">Gavrilov VB, Gavrilova AR, Mazhul LM. Analysis of methods for determining the products of lipid peroxidation in blood serum by the test with thiobarbituric acid. Questions of medicinal chemistry. 1987;33(1):118-122. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Черняускене Р.Ч., Варшкявичене З.З., Грибаускас П.С. Одновременное определение концентраций витаминов Е и А в сыворотке крови // Лабораторное дело. — 1984. — № 6. — С. 362-365.</mixed-citation><mixed-citation xml:lang="en">ЧChernyauskene RCh, Varskevichene ZZ, Grybauskas PS. Simultaneous determination of the concentrations of vitamins E and A in blood serum. Laboratornoe delo. 1984;6:362-365. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Hisin PJ, Hilf R. Fluorоmetric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 1976;74:214-226.</mixed-citation><mixed-citation xml:lang="en">Hisin PJ, Hilf R. Fluorоmetric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 1976;74:214-226.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Kolesnikova LI, Shemyakina NA, Namokonov EV, et al. Some parameters of carbonyl and oxidative stress in patients with type 2 diabetes mellitus and macroangiopathy of the lower extremities. Diabetes Technol. Therapeutics. 2019:21(S1):46.</mixed-citation><mixed-citation xml:lang="en">Kolesnikova LI, Shemyakina NA, Namokonov EV, et al. Some parameters of carbonyl and oxidative stress in patients with type 2 diabetes mellitus and macroangiopathy of the lower extremities. Diabetes Technol. Therapeutics. 2019:21(S1):46.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Kolesnikova LI, Vlasov BY, Kolesnikov SI, et al. Intensity of oxidative stress in Mongoloid and Caucasian patients with type 1 diabetes mellitus. Bull. Exp. Biol. 2016;161(6):767-769. doi: https://doi.org/10.1007/s10517-016-3505-0</mixed-citation><mixed-citation xml:lang="en">Kolesnikova LI, Vlasov BY, Kolesnikov SI, et al. Intensity of oxidative stress in Mongoloid and Caucasian patients with type 1 diabetes mellitus. Bull. Exp. Biol. 2016;161(6):767-769. doi: https://doi.org/10.1007/s10517-016-3505-0</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Victor P, Umapathy D, George L, et al. Crosstalk between endoplasmic reticulum stress and oxidative stress in the progression of diabetic nephropathy. Cell Stress and Chaperones. 2021;26(2):311-321. doi: https://doi.org/10.1007/s12192-020-01176-z</mixed-citation><mixed-citation xml:lang="en">Victor P, Umapathy D, George L, et al. Crosstalk between endoplasmic reticulum stress and oxidative stress in the progression of diabetic nephropathy. Cell Stress and Chaperones. 2021;26(2):311-321. doi: https://doi.org/10.1007/s12192-020-01176-z</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Charlton A, Garzarella J, Jandeleit-Dahm KA, et al. Oxidative stress and inflammation in renal and cardiovascular complications of diabetes. Biology. 2021;10(1):18. doi: https://doi.org/10.3390/biology10010018</mixed-citation><mixed-citation xml:lang="en">Charlton A, Garzarella J, Jandeleit-Dahm KA, et al. Oxidative stress and inflammation in renal and cardiovascular complications of diabetes. Biology. 2021;10(1):18. doi: https://doi.org/10.3390/biology10010018</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat. Rev. Mol. Cell Biol. 2020;21(7):363-383. doi: https://doi.org/10.1038/s41580-020-0230-3</mixed-citation><mixed-citation xml:lang="en">Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat. Rev. Mol. Cell Biol. 2020;21(7):363-383. doi: https://doi.org/10.1038/s41580-020-0230-3</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Даренская М.А., Колесникова Л.И., Колесников С.И. Окислительный стресс: патогенетическая роль в развитии сахарного диабета и его осложнений, терапевтические подходы к коррекции // Бюллетень экспериментальной биологии и медицины. — 2021. — Т. 171. — №2. — C. 136-149. doi: https://doi.org/10.47056/0365-9615-2021-171-2-136-149</mixed-citation><mixed-citation xml:lang="en">Darenskaya MA, Kolesnikova LI, Kolesnikov SI. Oxidative stress: pathogenetic role in the development of diabetes mellitus and its complications, therapeutic approaches to correction. Bulletin of Experimental Biology and Medicine. 2021;171(2):136-149. (In Russ.). doi: https://doi.org/10.47056/0365-9615-2021-171-2-136-149</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Sanchez M, Roussel R, Hadjadj S, et al. Plasma concentrations of 8-hydroxy-2′-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetes. Diabetologia. 2018;61:977-984. doi: https://doi.org/10.1007/s00125-017-4510-1</mixed-citation><mixed-citation xml:lang="en">Sanchez M, Roussel R, Hadjadj S, et al. Plasma concentrations of 8-hydroxy-2′-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetes. Diabetologia. 2018;61:977-984. doi: https://doi.org/10.1007/s00125-017-4510-1</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Qi H, Casalena G, Shi S, et al. Glomerular endothelial mitochondrial dysfunction is essential and characteristic of diabetic kidney disease susceptibility. Diabetes. 2017;66:763-778. doi: https://doi.org/10.2337/db16-0695</mixed-citation><mixed-citation xml:lang="en">Qi H, Casalena G, Shi S, et al. Glomerular endothelial mitochondrial dysfunction is essential and characteristic of diabetic kidney disease susceptibility. Diabetes. 2017;66:763-778. doi: https://doi.org/10.2337/db16-0695</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Чистякова О.В., Сухов И.Б., Шпаков А.О. Роль окислительного стресса и антиоксидантных ферментов в развитии сахарного диабета // Российский физиологический журнал им. И.М. Сеченова. — 2017. — Т. 103. — №9. — С. 987-1003.</mixed-citation><mixed-citation xml:lang="en">Chistyakova OV, Sukhov IB, Shpakov AO. The role of oxidative stress and antioxidant enzymes in the development of diabetes mellitus. I.M. Sechenov Physiological Journal. 2017;103(9):987-1003. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Marí M, de Gregorio E, de Dios C, et al. Mitochondrial glutathione: recent insights and role in disease. Antioxidants. 2021;9(10):909. doi: https://doi.org/10.3390/antiox9100909</mixed-citation><mixed-citation xml:lang="en">Marí M, de Gregorio E, de Dios C, et al. Mitochondrial glutathione: recent insights and role in disease. Antioxidants. 2021;9(10):909. doi: https://doi.org/10.3390/antiox9100909</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Silvagno F, Vernone A, Pescarmona GP. The role of glutathione in protecting against the severe inflammatory response triggered by COVID-19. Antioxidants. 2020;9(7):624. doi: https://doi.org/10.3390/antiox9070624</mixed-citation><mixed-citation xml:lang="en">Silvagno F, Vernone A, Pescarmona GP. The role of glutathione in protecting against the severe inflammatory response triggered by COVID-19. Antioxidants. 2020;9(7):624. doi: https://doi.org/10.3390/antiox9070624</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Bebu I, Braffett BH, Schade D, et al. An observational study of the equivalence of age and duration of diabetes to glycemic control relative to the risk of complications in the combined cohorts of the DCCT/EDIC study. Diabetes care. 2020;43(10):2478-2484. doi: https://doi.org/10.2337/dc20-0226</mixed-citation><mixed-citation xml:lang="en">Bebu I, Braffett BH, Schade D, et al. An observational study of the equivalence of age and duration of diabetes to glycemic control relative to the risk of complications in the combined cohorts of the DCCT/EDIC study. Diabetes care. 2020;43(10):2478-2484. doi: https://doi.org/10.2337/dc20-0226</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
